(Q43059651)

13 November 2017

title

Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy (English)

1 reference

13 November 2017

Qing Gao

1

1 reference

13 November 2017

Wenwen Shen

2

1 reference

13 November 2017

Weisong Qin

3

1 reference

13 November 2017

Chunxia Zheng

4

1 reference

13 November 2017

Mingchao Zhang

5

1 reference

13 November 2017

Caihong Zeng

6

1 reference

13 November 2017

Shengyu Wang

7

1 reference

13 November 2017

Jianping Wang

8

1 reference

13 November 2017

Xiaodong Zhu

9

1 reference

13 November 2017

Zhihong Liu

10

1 reference

13 November 2017

language of work or name

English

0 references

publication date

18 May 2010

1 reference

Nephrology Dialysis Transplantation

13 November 2017

published in

1 reference

13 November 2017

volume

25

1 reference

13 November 2017

issue

11

1 reference

13 November 2017

page(s)

3539-3547

1 reference

Proteinuria in diabetic kidney disease: a mechanistic viewpoint

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Standards of medical care in diabetes--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Effect of retinoic acid in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Normalization of obesity-associated insulin resistance through immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Effect of lipid reduction on the progression of renal disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Where does albuminuria come from in diabetic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Insulin resistance contributes to obesity-related proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

The spectrum of podocytopathies: a unifying view of glomerular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

Interactions between renin angiotensin system and advanced glycation in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ245

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ245

1 reference

13 November 2017

1 reference